Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Douglas

Showing results (71-80 of 122) with videos related to

Pageof 13
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2008
Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptorJian-Ping Lai, Saien Lai, Florin Tuluc, et al.
The Journal of Infectious Diseases|March 20, 2004
Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in childrenAkihiko Saitoh, Christine A Powell, Terence Fenton, et al.
Psycho-Oncology|August 19, 2003
The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesionsCarolyn Y Fang, Suzanne M Miller, Megan Mills, et al.
Neuroimmunomodulation|August 6, 2008
Innate immune markers in mothers and fathers of children newly diagnosed with cancerMeredith J Lutz Stehl, Anne E Kazak, Wei-Ting Hwang, et al.
Plos One|September 21, 2011
A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsPablo Tebas, Florin Tuluc, Jeffrey S Barrett, et al.
Journal of Leukocyte Biology|October 7, 2008
Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)Irene Chernova, Jian-Ping Lai, Haiying Li, et al.
Journal of Neuroscience Research|January 27, 2004
A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neuronsXu Wang, Steven D Douglas, Kathryn G Commons, et al.
CNS Spectrums|March 11, 2003
Depression and HIV infection: impact on immune function and disease progressionDean G Cruess, John M Petitto, Jane Leserman, et al.
Current Psychiatry Reports|November 12, 2003
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus diseaseDean G Cruess, Steven D Douglas, John M Petitto, et al.
The American Journal of Psychiatry|November 3, 2005
Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive womenDean G Cruess, Steven D Douglas, John M Petitto, et al.
Pageof 13

Showing results (71-80 of 122) with videos related to

Sort By:
Pageof 13
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2008
Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptorJian-Ping Lai, Saien Lai, Florin Tuluc, et al.
The Journal of Infectious Diseases|March 20, 2004
Longitudinal analysis of lymphocyte ratios and HIV-1 intracellular DNA levels in childrenAkihiko Saitoh, Christine A Powell, Terence Fenton, et al.
Psycho-Oncology|August 19, 2003
The effects of avoidance on cytotoxic/suppressor T cells in women with cervical lesionsCarolyn Y Fang, Suzanne M Miller, Megan Mills, et al.
Neuroimmunomodulation|August 6, 2008
Innate immune markers in mothers and fathers of children newly diagnosed with cancerMeredith J Lutz Stehl, Anne E Kazak, Wei-Ting Hwang, et al.
Plos One|September 21, 2011
A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adultsPablo Tebas, Florin Tuluc, Jeffrey S Barrett, et al.
Journal of Leukocyte Biology|October 7, 2008
Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)Irene Chernova, Jian-Ping Lai, Haiying Li, et al.
Journal of Neuroscience Research|January 27, 2004
A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-kappa B promoter activation in human NT2-N neuronsXu Wang, Steven D Douglas, Kathryn G Commons, et al.
CNS Spectrums|March 11, 2003
Depression and HIV infection: impact on immune function and disease progressionDean G Cruess, John M Petitto, Jane Leserman, et al.
Current Psychiatry Reports|November 12, 2003
Association of depression, CD8+ T lymphocytes, and natural killer cell activity: implications for morbidity and mortality in Human immunodeficiency virus diseaseDean G Cruess, Steven D Douglas, John M Petitto, et al.
The American Journal of Psychiatry|November 3, 2005
Association of resolution of major depression with increased natural killer cell activity among HIV-seropositive womenDean G Cruess, Steven D Douglas, John M Petitto, et al.
Pageof 13